{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:59:05Z","timestamp":1715533145451},"reference-count":72,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"vor","delay-in-days":2037,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:p> <jats:italic>Rapidly accumulating clinical data have repeatedly demonstrated not only the critical importance of even small increases in blood pressure as a pathophysiologic factor in the development of cardiovascular disease, particularly in individuals with diabetes mellitus, but also the therapeutic necessity of more aggressive blood pressure reduction and the achievement of progressively lower blood pressure targets in reducing cardiovascular event rates. JNC VI has defined optimal blood pressure as \u2264120\/80 mm Hg, and Stage 1 hypertension as \u2265140\/80 mm Hg. Target blood pressures are now \u2264130\/80 mm Hg in patients with diabetes and &lt;125\/75 mm Hg for patients with hypertensive renal disease with proteinuria of&gt;1 gm\/24 hours. Achieving such target pressures is increasingly difficult, particularly in diabetic patients with chronic renal disease, who require complex multidrug antihypertensive regimens. This review attempts to provide some suggestions for constructing such antihypertensive regimens, and provides considerations for the appropriate use of diuretics and the most effective drug combinations. Factors potentially contributing to drug resistant hypertension include such problems as failure to maximize drug dosing, suboptimal diuretic use, noncompliance, and possible confounding effects of such concomitant medications as nonsteroidal and anti\u2010inflammatory drugs or decongestants. The issues underlying drug\u2010resistant hypertension are listed, together with strategies for overcoming this problem.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1524-6175.2001.00469.x","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T08:28:55Z","timestamp":1180600135000},"page":"346-353","source":"Crossref","is-referenced-by-count":11,"title":["Beyond the Usual Strategies for Blood Pressure Reduction: Therapeutic Considerations and Combination Therapies"],"prefix":"10.1111","volume":"3","author":[{"given":"Thomas D.","family":"Giles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary E.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.16225"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)22024-1"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(98)00197-6"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02521-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903043400902"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.4.1043"},{"key":"e_1_2_6_12_2","first-page":"1175","article-title":"Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds","volume":"265","author":"Calder JA","year":"1993","journal-title":"J Pharmacol Exp Therap"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00267-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.35.5.1025"},{"issue":"2","key":"e_1_2_6_15_2","first-page":"97S","article-title":"Racial differences in response to low\u2010dose captopril are abolished by addition of hydrochlorothiazide","volume":"14","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/ajh\/5.12.875","article-title":"Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients","volume":"5","author":"Giles TD","year":"1992","journal-title":"Am J Hypertens"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-7-200010030-00010"},{"issue":"6","key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/00005344-199312050-00017","article-title":"Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study","volume":"22","author":"Senior R","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_6_20_2","first-page":"74","volume-title":"Drugs for the Heart","author":"Opie LH","year":"1991"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045415-199907000-00012"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)74868-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001013"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.12.1342"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01301-7"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199002000-00015"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210013271406"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.5.1115"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.4.950"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.38.1.90"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-5-199709010-00001"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04433-X"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341502"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10363-X"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.5.685"},{"key":"e_1_2_6_37_2","first-page":"205","article-title":"Angiotensin II receptors and angiotensin II receptor antagonists","volume":"45","author":"Timmermans PB","year":"1993","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00104-1"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.00829.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1053\/pcad.1999.0410265"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1076-7460.2001.90859.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004872-200018010-00013","article-title":"Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease","volume":"18","author":"Ruilope LM","year":"2000","journal-title":"J Hypertens"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70416-6"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00220-4"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.00444.x"},{"key":"e_1_2_6_46_2","first-page":"11","article-title":"Treatment with beta\u2010blockers for the primary prevention of the cardiovascular complications of hypertension","volume":"20","author":"Staessen JA","year":"1999","journal-title":"Eur Heart J"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-9-199911020-00003"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00005-9"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641968809046803"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.80.1.45"},{"key":"e_1_2_6_51_2","first-page":"2209","volume-title":"Hypertension: Pathophysiology, Diagnosis, and Management","author":"Waeber B","year":"1990"},{"issue":"5","key":"e_1_2_6_52_2","first-page":"S37","article-title":"Resting and exercise blood pressure with atenolol, enalapril and a low\u2010dose combination","volume":"5","author":"Franz IW","year":"1987","journal-title":"J Hypertens"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198507001-00016"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.1967"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.27.040187.002023"},{"key":"e_1_2_6_56_2","first-page":"1","volume-title":"Calcium Antagonists in Clinical Medicine","author":"Triggle DJ","year":"1992"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803053381003"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.597"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00751-6"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00114-4"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.5.1088"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00781-3"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)08359-6"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-185"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.63.4.844"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0034091"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198835020-00003"},{"key":"e_1_2_6_68_2","first-page":"564","volume-title":"Hypertension: A Companion to Brenner and Rector's 'The Kidney'","author":"Vidt DG","year":"2000"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400090078014"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199717050-00001"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80049-0"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.36.3.461"},{"key":"e_1_2_6_73_2","first-page":"83","volume-title":"Drugs for the Heart","author":"Opie LH","year":"1997"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2001.00469.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2001.00469.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:58:39Z","timestamp":1697633919000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2001.00469.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1111\/j.1524-6175.2001.00469.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2001.00469.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}